Alnylam Pharmaceuticals
Manager, Global Planning (Finance)
Alnylam is the world's leading RNA interference (RNAi) company.
Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality by harnessing the power of RNAi for human health as an innovative new class of medicines. We are a growing biopharmaceutical company with three approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.
Headquartered in Cambridge, Mass., Alnylam employs over 1,500 people in 19 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work six years in a row (2015-2020), a Great Place to Work in the U.K. and Switzerland two years in a row (2019-2020) and a Science Magazine's Top Employer two years in a row (2019-2020). Please visit www.alnylam.com for more information.
The Manager, Global Planning role is key to supporting the Global Supply Planning Organization for future growth. The role is responsible for ensuring uninterrupted supply to all Alnylam patients both late-stage clinical and commercial, in line with corporate and program objectives. The position entails building strong cross-functional relationships throughout the organization, understanding overall program risk, providing scenario planning and generating an achievable produciton plan. The Manager role has high visibility across the organizaiton and allows the individual the opportunity to develop their career through multiple process development opportunities in line with the rapid growth of the Alnylam pipeline.
Summary of Key Responsibilities